What can we expect the US life sciences sector to look like over the course of the next four years…
… as Donald Trump takes up his presidency? The election outcome has certainly sparked more discussion than we typically see during an administration change. Traditionally, there’s a transition period with expectations of continuity, but this time feels different. The team of The Medicine Maker have discussed with Ali Pashazadeh, Treehill Partners CEO – read the […]